Ancient Canadian fault could produce major earthquakes in the future
The team used high-resolution images from satellites, airplanes, and drones. They found a 130-km-long fault segment near Dawson City, suggesting seismic activity in the Quaternary Period, dating from 2.6 million years ago to today.
"Over the past couple of decades, there have been a few small earthquakes of magnitude 3 to 4 detected along the Tintina fault, but nothing to suggest it is capable of large ruptures," Theron Finley, recent UVic PhD graduate and lead author of the recent article, says in a statement.
"The expanding availability of high-resolution data prompted us to re-examine the fault, looking for evidence of prehistoric earthquakes in the landscape."
Canada's current understanding of earthquake frequency and risk is limited to the last couple of hundred years, the authors say, and it is comprised of data derived from Indigenous records, historical archives, and modern technology.
'However, for many active faults, thousands of years can elapse between large ruptures,' the authors say in a statement.
Large or shallow quakes can rupture Earth's surface, creating a linear feature in the land known as a fault scrap. This feature, which can be hundreds of kilometres long, can remain for tens of thousands of years and provide insight into seismic activity in the area. They're notoriously difficult to detect, especially in Canada's dense forests.
The high-resolution topographic data used in the study is one of the best ways to detect fault scraps.
It revealed glacial landforms that formed about 2.6 million years ago were laterally offset across a fault scrap by 1000 metres. Some that are 132,000 years old are offset by 75 metres.
'These findings confirm that the fault has slipped in multiple earthquakes throughout the Quaternary period, likely slipping several meters in each event. What's more, landforms known to be 12,000 years old are not offset by the fault, indicating no large ruptures have occurred since that time. The fault continues to accumulate strain at an average rate of 0.2 to 0.8 millimetres per year, and therefore poses a future earthquake threat,' the authors write in a statement.
Finley says future earthquakes on the Tintina fault could be major, exceeding a mangitude 7.5, potentially causing severe shaking in Dawson City, a community with a population of about 2,350 people.
'Compounding the hazard from seismic shaking, the region is prone to landslides, which could be seismically triggered. The Moosehide landslide immediately north of Dawson City and the newly discovered Sunnydale landslide directly across the Yukon River both show ongoing signs of instability,' the authors write.
The research will be shared with local authorities, governments, and infrastructure planners to help mitigate risk.
Earthquake frequency in Canada
Small earthquakes are common in Canada, with the Geological Survey of Canada recording and locating an average of 4,000 earthquakes annually, or 11 per day, nationwide.
Header image: Approximate location of the Tintina fault. Cheryl Santa Maria for The Weather Network.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Gizmodo
2 hours ago
- Gizmodo
Humans Counted 8,600 Earthquakes in Yellowstone. AI Says We're Not Even Close
Before the advent of artificial intelligence, experts often detected earthquakes by analyzing seismic data by hand. Unsurprisingly, this approach takes a long time, is cost-intensive, and usually identifies fewer earthquakes. Machine learning has now changed virtually everything. Using artificial intelligence, researchers have retroactively identified and assigned magnitudes to ten times as many seismic events in historical earthquake data from the Yellowstone caldera from 2008 to 2022 as had been previously registered. 'If we had to do it old school with someone manually clicking through all this data looking for earthquakes, you couldn't do it. It's not scalable,' Western University engineer Bing Li explained in a university statement. 'We leverage leading-edge deep learning algorithms and a detailed three-dimensional velocity model to construct a 15-year high-resolution earthquake catalog of the Yellowstone caldera region,' Li and colleagues explained in their study, published earlier this month in the journal Science Advances. Thanks to this approach, Yellowstone caldera's earthquake data from 2008 to 2022 now consists of 86,276 earthquakes, all of which strengthen seismologists' understanding of volcanic and seismic systems. Calderas, like Yellowstone's, are essentially ancient volcanoes that erupt and then collapse into their emptied magma chamber, leaving a large depression in the land. Many features related to volcanoes can cause earthquakes, and most of the ones at Yellowstone are brittle-failure events—when stress in the crust causes rocks to break. The study found that over half of Yellowstone's earthquakes are part of earthquake swarms—sequences of earthquakes that don't follow the mainshock-aftershock seismic pattern that most people are familiar with. 'While Yellowstone and other volcanoes each have unique features, the hope is that these insights can be applied elsewhere,' said Li, who is also an expert in fluid-induced earthquakes and rock mechanics. 'By understanding patterns of seismicity, like earthquake swarms, we can improve safety measures, better inform the public about potential risks and even guide geothermal energy development away from danger in areas with promising heat flow.' According to the study, earthquake swarms beneath the Yellowstone caldera took place along more immature fault structures—underdeveloped faults that have accumulated fewer 'slips' than mature fault structures. Myanmar's Devastating Earthquake in March Split the Earth at 'Supershear Velocity' While researchers expect more aftershocks along immature faults, 'to a large extent, there is no systematic understanding of how one earthquake triggers another in a swarm. We can only indirectly measure space and time between events,' said Li. 'But now, we have a far more robust catalogue of seismic activity under the Yellowstone caldera, and we can apply statistical methods that help us quantify and find new swarms that we haven't seen before, study them, and see what we can learn from them.' It goes to show that even the world's first national park still has secrets in store for researchers—like a brand new hole that recently opened up in Yellowstone's Norris Geyser Basin.


Medscape
3 hours ago
- Medscape
Chronic Conditions Raise Risk for RSV Hospitalizations
TOPLINE: Children with chronic medical conditions (CMCs) had higher rates of respiratory syncytial virus (RSV)-related hospitalization than healthy children during their first two RSV seasons, with a sustained elevated risk in the second year. METHODOLOGY: Researchers conducted a retrospective population-based cohort study to identify children with CMCs who were at a higher risk for RSV-related hospitalizations during their first and second RSV seasons. They enrolled 431,937 children (51.4% boys) born in British Columbia, Canada, between April 2013 and March 2023, with or without a CMC, identified through the provincial health registry. The children were followed up until the day before their third RSV season or April 1, 2024, whichever came early. They compared RSV-related hospitalizations between 25,452 children diagnosed with at least one of 1116 distinct CMCs within their first 2 years of life and those without CMCs. The primary outcome was hospitalization due to RSV-related lower respiratory tract infection. Secondary outcomes included pediatric ICU admissions, hospital length of stay, and use of invasive mechanical ventilation. TAKEAWAY: In the first RSV season, the hospitalization rate per 1000 person-years was 15.9 (95% CI, 14.2-17.6) for children with CMCs and 8.0 (95% CI, 7.7-8.3) for those without CMCs. In the second season, the rate was 7.8 (95% CI, 6.7-8.8) for those with CMCs and 2.2 (95% CI, 2.1-2.3) without CMCs. Children with CMCs had longer hospital and pediatric ICU stays and required mechanical ventilation more frequently during their first two RSV seasons than healthy children. RSV-related hospitalization rates in the second season among children with CMCs involving the respiratory, cardiovascular, or gastrointestinal systems were twofold higher than the overall hospitalization rate in the first season. Moreover, children with Down syndrome or those born at less than 28 weeks of gestation had fivefold higher RSV-related hospitalization rates in the second season than all children in the first season. IN PRACTICE: 'Understanding the regional burden of RSV disease is critical to inform local RSV immunization guidelines. In regions with high IRs [incidence rates], a universal RSV prophylaxis program may be warranted. However, in jurisdictions with a lower burden of disease, targeted programs for children at high risk in their second RSV season may be more cost-effective,' the authors wrote. SOURCE: The study was led by Marina Viñeta Paramo, MBBS, Department of Pediatrics, University of British Columbia in Vancouver, British Columbia, Canada. It was published online on July 8, 2025, in JAMA Network Open. LIMITATIONS: The use of retrospective health administrative data may have introduced biases due to coding variability and misclassification of RSV cases. The analysis did not account for the timing of CMC diagnoses or treatments received. The frequent co-occurrence of extreme prematurity in children with CMCs limited the ability to separate their independent effects. Additionally, the database excluded children not registered for provincial health insurance at birth, potentially omitting vulnerable populations. DISCLOSURES: This study was supported by financial aid to three authors, including funding from the British Columbia Children's Hospital Foundation. Two authors received financial support or a scholar award from Michael Smith Health Research BC. One author received grants from Merck, GlaxoSmithKline, Sanofi Pasteur, Moderna, and Pfizer. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.


Medscape
3 hours ago
- Medscape
Top 3 Chronic Urticaria Treatments Highlighted in Meta-Analysis
In managing antihistamine-refractory chronic urticaria, omalizumab and remibrutinib stand out among the most effective treatments across multiple patient-important outcomes, followed by dupilumab, which shows improvement in urticaria activity, according to a meta-analysis of 42 systemic treatments in 93 studies. All three treatments for chronic urticaria, a condition defined by wheal and itch symptoms persisting 6 weeks or more, have favorable safety profiles, according to the researchers, led by Alexandro W. L. Chu, MD, with the Department of Medicine and the Evidence in Allergy Group at McMaster University in Hamilton, Ontario, Canada. Findings were published in The Journal of Allergy and Clinical Immunology as part of an update of chronic urticaria guidelines for the American Academy of Allergy, Asthma & Immunology (AAAAI), American College of Allergy, Asthma & Immunology (ACAAI), and Joint Task Force on Practice Parameters (JTFPP). The meta-analysis examined patient-important outcomes beyond itch and wheal assessment such as angioedema, sleep quality, urticaria- and angioedema-related quality of life, and adverse events at the longest available time point. The researchers used measures including the 7-day Urticaria Activity Score, Chronic Urticaria Quality of Life Questionnaire and Angioedema Quality of Life Questionnaire. Dupilumab improves itch and wheals, 'but it is uncertain whether it improves angioedema or quality of life,' the researchers wrote. Cyclosporine, while it may be among the most effective, the analysis noted, may also be among the most harmful treatments with a high frequency of adverse events. In the intermediate range of effectiveness is low-dose omalizumab (doses below the standard 300 mg or administration less frequent than every 4 weeks) and that low dose also has a favorable safety profile, the data showed. 'Azathioprine, dapsone, hydroxychloroquine, mycophenolate, sulfasalazine, and vitamin D may improve outcomes, while benralizumab, quilizumab, and tezepelumab may not differ from placebo, though the evidence is uncertain,' the report stated. 'Findings were consistent across age groups and baseline severity and were robust to subgroup analyses.' Patients' comorbidities may also steer treatment selection, the authors wrote. 'For instance, patients with concomitant food allergies may favor omalizumab, while those with chronic rhinosinusitis with nasal polyposis or atopic dermatitis may favor dupilumab.' Remibrutinib Rachel Meltzer, MD, MPH, director of the Pruritus Clinic at Brigham and Women's Hospital and instructor in dermatology at Harvard Medical School, both in Boston, told Medscape Medical News the most important aspect of the meta-analysis is the side-by-side comparison of the treatments, particularly the comparison with the bruton tyrosine kinase inhibitor remibrutinib, which, she noted, is not yet approved by the FDA for any indication in dermatology. 'The only people who have any clinical experience with it are the people running the trials at the moment,' she said, and information from them indicates that 'remibrutinib does sound promising. The exciting thing is that it's an oral medicine and it seems to have a good safety and efficacy profile, whereas now, if someone fails our standard oral regimen, the move frequently has been to go to Zolair/omalizumab or less frequently in dermatology, cyclosporine.' 'Omalizumab has been approved for quite some time and that's been kind of the go-to if you need to escalate therapy if people fail the first-line high-dose antihistamines,' she said. Dupilumab, she said, 'wouldn't be the first thing I'd try unless someone had a comorbidity of atopic dermatitis or asthma or allergic rhinitis with nasal polyps,' she said. It was approved in April for chronic spontaneous urticaria. This is the first review of chronic urticaria treatments that has 'systematically analyzed the overall relative benefits and harms of all available options or appraised the evidence using robust and standardized approaches,' the authors wrote. This study was commissioned by the AAAAI and the ACAAI through the JTFPP. Several authors reported multiple ties to pharmaceutical companies, which are available with the full text. Meltzer reported no relevant financial relationships.